These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Synergistic effect of FK 506 and donor-specific blood transfusion on rat skin but not on composite tissue (limb) allograft survival. Kuroki H, Bean MA, Ikuta Y, Burgess EM. Transplant Proc; 1991 Dec; 23(6):3282-4. PubMed ID: 1721436 [No Abstract] [Full Text] [Related]
8. Morphological and immunological analysis of rats with long-term-surviving limb allografts induced by a short course of FK 506 or cyclosporine. Kuroki H, Ishida O, Daisaku H, Fukuhara K, Hatano E, Murakami T, Ikuta Y, Matsumoto AK, Akiyama M. Transplant Proc; 1991 Feb; 23(1 Pt 1):516-20. PubMed ID: 1703697 [No Abstract] [Full Text] [Related]
9. Donor leukocytes combine with immunosuppressive drug therapy to prolong limb allograft survival. Kanatani T, Lanzetta M, Owen E, Matsumoto T, Fujioka H, Kurosaka M, McCaughan GW, Bishop GA. Transplant Proc; 2005 Jun; 37(5):2382-4. PubMed ID: 15964421 [Abstract] [Full Text] [Related]
15. Is donor-specific blood transfusion effective for strong minor histocompatibility antigen barriers? Hara MH, Suzuki H, Shibata K, Tanigawa M, Sekiya R, Matsuzaki Y, Onitsuka T, Koga Y, Yamashita A, Miyamoto M, Suzuki S, Amemiya H, Kimura H. Transplant Proc; 1996 Jun; 28(3):1268-9. PubMed ID: 8658654 [No Abstract] [Full Text] [Related]
16. Comparison of the effect of a 5-mg/kg and 10-mg/kg cyclosporine loading dose with single and multiple donor-specific transfusions on rat cardiac allograft survival. Fisher RA, Cohen DS, Alexander JW, Davies CB, Schroeder TJ. Transplant Proc; 1994 Oct; 26(5):3056-9. PubMed ID: 7940961 [No Abstract] [Full Text] [Related]